Evidence map›Paper›PMID 27353165›Full record

ArticleThe Journal of antibiotics2016

Pyrazinone protease inhibitor metabolites from Photorhabdus luminescens.

Hyun Bong Park, Jason M Crawford

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of antibiotics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 23 citations in OpenAlex.

  1. ExploringMolecules (Basel, Switzerland) · 2024
    Review
  2. Review
  3. Article
  4. Frontiers in microbiology · 2022
    Review
  5. Article
  6. Article
  7. Stilbene epoxidation and detoxification in aThe Journal of biological chemistry · 2017
    Article
  8. Microbiology: A new language for small talk.Nature chemical biology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Hyun Bong ParkDepartment of Chemistry, Yale University, New Haven, CT, USA.
Jason M CrawfordDepartment of Chemistry, Yale University, New Haven, CT, USA.
Yale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Cryptic gut bacterial metabolites that regulate colorectal cancer formationDP2CA186575 · NCI · YALE UNIVERSITY · PI CRAWFORD, JASON MICHAEL · 2013 to 2013
$2.5M
Ecological triggers to exploit antibiotic and virulence factor regulationR00GM097096 · NIGMS · YALE UNIVERSITY · PI CRAWFORD, JASON MICHAEL · 2012 to 2014
$721k
NCATS NIH HHS UL1 TR001863NCI NIH HHS DP2 CA186575NIGMS NIH HHS R00 GM097096
6 · The paper itself

Abstract

Photorhabdus luminescens is a bioluminescent entomopathogenic bacterium that undergoes phenotypic variation and lives in mutualistic association with nematodes of the family Heterorhabditidae. The pair infects and kills insects, and during their coordinated lifecycle, the bacteria produce an assortment of specialized metabolites to regulate its mutualistic and pathogenic roles. As part of our search for new specialized metabolites from the Photorhabdus genus, we examined organic extracts from P. luminescens grown in an amino-acid-rich medium based on the free amino-acid levels found in the circulatory fluid of its common insect prey, the Galleria mellonella larva. Reversed-phase HPLC/UV/MS-guided fractionation of the culture extracts led to the identification of two new pyrazinone metabolites, lumizinones A (1) and B (2), together with two N-acetyl dipeptides (3 and 4). The lumizinones were produced only in the phenotypic variant associated with nematode development and insect pathogenesis. Their chemical structures were elucidated by analysis of 1D and 2D NMR and high-resolution ESI-QTOF-MS spectral data. The absolute configurations of the amino acids in 3 and 4 were determined by Marfey's analysis. Compounds 1-4 were evaluated for their calpain protease inhibitory activity, and lumizinone A (1) showed inhibition with an IC50 (half-maximal inhibitory concentration) value of 3.9 μm.

Indexed as

Amino AcidsAnimalsChromatography, High Pressure LiquidInhibitory Concentration 50LepidopteraMagnetic Resonance SpectroscopyMass SpectrometryPhotorhabdusProtease InhibitorsPyrazinesSpectrometry, Mass, Electrospray IonizationAmino AcidsProtease InhibitorsPyrazines

Identifiers

PMID27353165
PMCPMC5003743
OpenAlexW2471488268

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.